Simplify Logo
Electromed

Electromed

Designs and markets airway clearance devices

Marketing Coordinator

Full-Time
$50k - $64k/yr

+ Performance-based incentives

Mid
Bachelor's
New Prague, MN, USA
Hybrid

Hybrid position based in New Prague, Minnesota; candidates must live within commuting distance.

About the job

Requirements
  • A bachelor's degree in Marketing, Communications, Project Management, or a related field.
  • At least 3 years of experience in a marketing coordination, marketing operations, project management, or marketing support role.
  • Strong organization and project management skills with exceptional attention to detail.
  • Strong analytical skills with experience gathering, organizing, and reporting data in a clear and actionable format.
  • Working knowledge of print production processes, specifications, and paper finishing options.
  • Excellent written, proofreading, and verbal communication skills.
  • Proficiency with Microsoft Office.
  • Ability to work independently, anticipate needs, solve problems, and complete projects with limited direction in an environment of competing priorities.
  • A collaborative mindset for working cross-functionally to drive company-wide initiatives.
  • Ability to organize, manage, and complete multiple projects with limited direction to meet tight deadlines in an environment of competing priorities.
  • Located within commuting distance of New Prague, Minnesota.
Responsibilities
  • Manage inbound marketing project requests, clarify project requirements, establish project timelines, and coordinate reviews, approvals, and delivery.
  • Drive the Electromed editorial calendar, project trackers, and status reports to ensure cross-functional visibility and on-time delivery of marketing initiatives.
  • Monitor priorities, deadlines, and risks, escalate issues, and recommend solutions to keep projects on schedule.
  • Partner with the Marketing Designer to coordinate project inputs, copy and content readiness, reviews, print production, file delivery, and final material availability.
  • Coordinate cross-functional reviews and approvals, including routing materials through compliance signoff processes.
  • Manage relationships with printers and other external marketing service partners, including coordinating print production from estimate through delivery, proof review, production schedules, inventory requirements, shipping, and quality control.
  • Maintain print and digital asset libraries, ensuring proper version control, tracking inventory levels and material availability, and coordinating reprints when needed.
  • Monitor collateral inventory and usage, coordinate reprints, and recommend order quantities based on anticipated demand.
  • Develop and maintain recurring marketing reports, dashboards, campaign summaries, and post-program analyses to support informed decision-making.
  • Support day-to-day and month-end marketing activities, initiatives, and reporting needs.
  • Identify and recommend improvements to marketing workflows, templates, tools, reporting, and documentation to increase efficiency, consistency, and visibility.
  • Work across teams to provide resources and tools that support the commercial organization in achieving growth goals.
Desired Qualifications
  • Familiarity with Salesforce customer relationship management software.
  • Familiarity with Asana project management software.

About the company

Electromed, Inc. designs, manufactures, and markets medical devices that provide airway clearance therapy. Its flagship product, the SmartVest Airway Clearance System, uses high frequency chest wall oscillation (HFCWO) to help people clear excess mucus from the lungs, aiding those with impaired airway clearance. The system is designed for home and clinical use, delivering oscillating pressure to the chest to loosen and move mucus so it can be coughed out. The company differentiates itself by focusing specifically on airway clearance technology and offering a hands-on commitment to service, framed by its mission to help people breathe better and live more active, fulfilling lives. Electromed’s goal is to make life’s important moments possible—one breath at a time.

Company Size

201-500

Company Stage

IPO

Headquarters

New Prague, Minnesota

Founded

1992

Get referred to Electromed

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 25, 2026 earnings follow 18.4% Q3 revenue growth and 58.8% net-income growth.
  • Cash was $17.0 million and debt remained zero on March 31, 2026.
  • Marathon Medical expanded SmartVest access to veterans, federal employees, and Native American communities.

What critics are saying

  • BMO’s $10 million revolver matures December 16, 2026, forcing refinancing or extension.
  • Electromed’s airway-clearance niche faces commoditization from larger respiratory-device rivals with broader salesforces.
  • Any claims-processing disruption or reimbursement pushback can choke cash conversion and damage growth.

What makes Electromed unique

  • SmartVest Clearway remains a newest HFCWO device, launched in late 2022.
  • Electromed’s Q3 2026 revenue reached $18.6 million, its 14th straight growth quarter.
  • The company claims 86% U.S. lives under contract, widening reimbursement access.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Unlimited Paid Time Off

401(k) Company Match

Health Insurance

Health Savings Account/Flexible Spending Account

Disability Insurance

Parental Leave

Wellness Program

Training Programs

Professional Development Budget

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Yahoo Finance
Aug 24th, 2026
Electromed Q4 2026 earnings on 25 August — GF Value sees 26% downside

Electromed Inc (ELMD) is scheduled to release its Q4 2026 earnings on 25 August 2026. Analysts expect quarterly revenue of $19.33 million and earnings of $0.32 per share. For the full year 2026, revenue is forecast at $73.60 million with earnings of $1.22 per share. These estimates have remained unchanged over the past 90 days. In the previous quarter, Electromed beat revenue expectations by 6.04% and earnings estimates by 44.03%, posting actual revenue of $18.58 million and earnings of $0.35 per share. The stock rose 25.11% following the results. Three analysts have set an average one-year price target of $40.33, suggesting 2.24% upside from the current price of $39.45. However, GuruFocus estimates a fair value of $29.08, implying 26.29% downside. The average brokerage recommendation is "outperform".

Business Wire
May 12th, 2026
Electromed reports record Q3 revenue of $18.6M, up 18%, with net income rising 59% to $3M

Electromed, a Minnesota-based airway clearance technology company, reported record financial results for its fiscal 2026 third quarter ended March 31. Net revenues increased 18.4% to $18.6 million, driven by an 18.6% rise in its core homecare market. Operating income surged 76.0% to a record $3.8 million, representing 20.3% of net revenues. Net income reached $3.0 million, or $0.35 per diluted share, up 58.8% year-over-year. The results marked Electromed's 14th consecutive quarter of year-over-year revenue and profit growth. The company ended the quarter with $17.0 million in cash, $28.3 million in accounts receivable, and no debt. CEO Jim Cunniff cited strategic investments in sales teams and 86% coverage of US lives under contract as positioning the company for continued growth.

Business Wire
Feb 10th, 2026
Electromed reports record Q2 revenue of $18.9M, up 16.3%, with net income rising 40.3% to $2.8M

Electromed, a leader in airway clearance technologies, reported record financial results for its fiscal 2026 second quarter ended 31 December 2025. Net revenues increased 16.3% to $18.9 million, driven by an 18.4% rise in its core homecare market. Operating income reached a record $3.6 million, up 42.4% year-over-year, whilst operating margin improved to 19.2% of net revenues. Net income rose 40.3% to $2.8 million, or $0.32 per diluted share. The company repurchased $2.8 million of common stock at an average price of $26.16 per share during the quarter and ended with $13.8 million in cash and no debt. This marks Electromed's 13th consecutive quarter of year-over-year revenue and net income growth.

TradingView
Dec 18th, 2025
Electromed Signs Credit Agreement With BMO Bank

Electromed entered a new senior secured revolving credit facility with BMO Bank for $10 million, maturing December 16, 2026 at one-month Term SOFR plus 1.75%. The facility is secured by a first-priority lien on substantially all assets and includes customary and financial covenants, including a min…

The Globe and Mail
Jul 29th, 2025
Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference

Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Company management will participate in the Canaccord Genuity 45 [th] Annual Growth Conference, which will be held August 12-14, 2025 in Boston, MA.